Prostate Cancer Therapeutics Market Size, Share & Trends Report

Prostate Cancer Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Zytiga, Gonax, Lupron, Zoladex, Decapeptyl, Eligard, Vantas, Casodex, Xtandi), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-1-68038-925-8
  • Number of Pages: 80
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Market Segmentation

  • Prostate Cancer Therapeutics Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
    • Hormonal Therapy
      • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
        • Zytiga
        • Gonax
      • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
        • Lupron
        • Zoladex
        • Eligard
        • Decapeptyl
        • Vantas
        • Others
      • Anti-Androgen
        • Xtandi
        • Casodex
    • Chemotherapy
      • Taxotere
      • Jevtana
    • Immunotherapy
      • Provenge
    • Targeted Therapy
      • Xofigo
    • Others
  • Prostate Cancer Therapeutics Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospital Pharmacies
    • Drug Stores & Retail Pharmacies
    • Online Pharmacies
  • Prostate Cancer Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Prostate Cancer Therapeutics Market, By Drug Class
        • Hormonal Therapy
          • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
            • Zytiga
            • Gonax
          • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
            • Lupron
            • Zoladex
            • Eligard
            • Decapeptyl
            • Vantas
            • Others
          • Anti-Androgen
            • Xtandi
            • Casodex
        • Chemotherapy
          • Taxotere
          • Jevtana
        • Immunotherapy
          • Provenge
        • Targeted Therapy
          • Xofigo
        • Others
      • North America Prostate Cancer Therapeutics Market, By Distribution Channel
        • Hospital Pharmacies
        • Drug Store & Retail Pharmacies
        • Online Pharmacies
      • U.S.
        • U.S. Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • U.S. Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • Canada
        • Canada Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • Canada Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
    • Europe
      • Europe Prostate Cancer Therapeutics Market, By Drug Class
        • Hormonal Therapy
          • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
            • Zytiga
            • Gonax
          • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
            • Lupron
            • Zoladex
            • Eligard
            • Decapeptyl
            • Vantas
            • Others
          • Anti-Androgen
            • Xtandi
            • Casodex
        • Chemotherapy
          • Taxotere
          • Jevtana
        • Immunotherapy
          • Provenge
        • Targeted Therapy
          • Xofigo
        • Others
      • Europe Prostate Cancer Therapeutics Market, By Distribution Channel
        • Hospital Pharmacies
        • Drug Store & Retail Pharmacies
        • Online Pharmacies
      • U.K.
        • U.K. Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • U.K. Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • Germany
        • Germany Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • Germany Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • France
        • France Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • France Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • Italy
        • Italy Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • Italy Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • Spain
        • Spain Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • Spain Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
    • Asia Pacific
      • Asia Pacific Prostate Cancer Therapeutics Market, By Drug Class
        • Hormonal Therapy
          • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
            • Zytiga
            • Gonax
          • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
            • Lupron
            • Zoladex
            • Eligard
            • Decapeptyl
            • Vantas
            • Others
          • Anti-Androgen
            • Xtandi
            • Casodex
        • Chemotherapy
          • Taxotere
          • Jevtana
        • Immunotherapy
          • Provenge
        • Targeted Therapy
          • Xofigo
        • Others
      • Asia Pacific Prostate Cancer Therapeutics Market, By Distribution Channel
        • Hospital Pharmacies
        • Drug Store & Retail Pharmacies
        • Online Pharmacies
      • Japan
        • Japan Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • Japan Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • China
        • China Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • China Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • India
        • India Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • India Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • South Korea
        • South Korea Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • South Korea Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • Australia
        • Australia Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • Australia Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
    • Latin America
      • Latin America Prostate Cancer Therapeutics Market, By Drug Class
        • Hormonal Therapy
          • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
            • Zytiga
            • Gonax
          • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
            • Lupron
            • Zoladex
            • Eligard
            • Decapeptyl
            • Vantas
            • Others
          • Anti-Androgen
            • Xtandi
            • Casodex
        • Chemotherapy
          • Taxotere
          • Jevtana
        • Immunotherapy
          • Provenge
        • Targeted Therapy
          • Xofigo
        • Others
      • Latin America Prostate Cancer Therapeutics Market, By Distribution Channel
        • Hospital Pharmacies
        • Drug Store & Retail Pharmacies
        • Online Pharmacies
      • Brazil
        • Brazil Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • Brazil Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • Mexico
        • Mexico Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • Mexico Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • Argentina
        • Argentina Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • Argentina Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
    • Middle East & Africa
      • Middle East & Africa Prostate Cancer Therapeutics Market, By Drug Class
        • Hormonal Therapy
          • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
            • Zytiga
            • Gonax
          • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
            • Lupron
            • Zoladex
            • Eligard
            • Decapeptyl
            • Vantas
            • Others
          • Anti-Androgen
            • Xtandi
            • Casodex
        • Chemotherapy
          • Taxotere
          • Jevtana
        • Immunotherapy
          • Provenge
        • Targeted Therapy
          • Xofigo
        • Others
      • Middle East & Africa Prostate Cancer Therapeutics Market, By Distribution Channel
        • Hospital Pharmacies
        • Drug Store & Retail Pharmacies
        • Online Pharmacies
      • South Africa
        • South Africa Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • South Africa Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • Saudi Arabia
        • Saudi Arabia Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • Saudi Arabia Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies
      • UAE
        • UAE Prostate Cancer Therapeutics Market, By Drug Class
          • Hormonal Therapy
            • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
              • Zytiga
              • Gonax
            • Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
              • Lupron
              • Zoladex
              • Eligard
              • Decapeptyl
              • Vantas
              • Others
            • Anti-Androgen
              • Xtandi
              • Casodex
          • Chemotherapy
            • Taxotere
            • Jevtana
          • Immunotherapy
            • Provenge
          • Targeted Therapy
            • Xofigo
          • Others
        • UAE Prostate Cancer Therapeutics Market, By Distribution Channel
          • Hospital Pharmacies
          • Drug Store & Retail Pharmacies
          • Online Pharmacies

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon